Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma
Clinical trial NCT01729091 · COMPLETED
Trial details
- NCT number
- NCT01729091
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-10
- Primary completion
- 2024-06-25
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.